Screener

R&D

Name: ImmunityBio, Inc. R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

ImmunityBio, Inc.·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Reportable Segment	$48.23M	$55.24M	$51.23M	$63.86M	$67.99M
Total	—	—	—	—	—

Reportable SegmentView metric